The Drug Regulatory Authority of Pakistan, with the Federal Government’s approval, has made amendments to the Bio-Study Rule 2017. Through this amendments, the Application Form (Form-IIA) for BA/BE Studies has been revised to rationalize the requirement for submission of the reference product’s Certificate of Pharmaceutical Products (CoPP). The Notification issued in this regard is as under:-
- SRO 678(I)/2023 Amendments in the Drug Pricing Policy-2018.
- Notification: Application on Form-5F (CTD) for Extension in the Contract Manufacturing Permission of Drugs.